• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Guideline-directed Therapy for Asthma & COPD: Use This, Not That

Article

Use ICS monotherapy for this, not that. For asthma COPD overlap, don't use that, use this. Try these 4 questions on GINA and GOLD recommended treatments.

Symptoms of asthma and COPD can sometimes overlap, complicating diagnosis and treatment. This quiz tests your knowledge of guideline-recommended issues surrounding treatment of asthma, COPD and asthma/COPD overlap, ie, when to use this, and not that.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Decrease in BMI Linked to Increased Risk for Severe Exacerbations, All-Cause Mortality in COPD / image credit weight loss/gain: ©missbobbit/stock.adobe.com

Decrease in BMI Linked to Increased Risk for Severe Exacerbations, All-Cause Mortality in COPD

April 19th 2024
Article

Among persons with COPD whose BMI decreased over a 4-year follow-up, mortality risk rose 70% compared with those whose BMI remained the same, researchers reported.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

New Research Suggests Cardiac Events are Prevalent in Older Adults Hospitalized with RSV / Image credit: ©Kateryna Kon/AdobeStock

New Research Suggests Cardiac Events are Prevalent in Older Adults Hospitalized with RSV

April 16th 2024
Article

Nearly one-quarter of hospitalized adults aged 50 years and older with RSV experienced an acute cardiac event, according to results of a new study.

Site Logo

Eternal Springs

January 13th 2010
Podcast

Doctors, especially primary care doctors, love stories. We love hearing them from patients and telling them to one another. “Anecdotal learning” it’s called by some (somewhat derisively because it’s not science).

FDA Approves Benralizumab as Add-On Maintenance Therapy for Children Aged 6-11 Years with Severe Asthma / Image credit: ©Argus/AdobeStock

FDA Approves Benralizumab as Add-On Maintenance Therapy for Children Aged 6-11 Years with Severe Asthma

April 11th 2024
Article

The additional indication for benralizumab was supported by data from the phase 3 TATE trial.

Pfizer: MONeT Study Topline Data Positive for Abrysvo in Adults Aged 18 to 59 Years at High Risk for RSV-LRTD / image credit Pfizer logo: cbies/stock.adobe.com

Pfizer: MONeT Study Topline Data Positive for Abrysvo in Adults Aged 18 to 59 Years at High Risk for RSV-LRTD

April 9th 2024
Article

Pfizer plans to submit the phase 3 MONeT data to regulatory bodies in support of an expanded label for Abrysvo to include adults aged 18 to 59, the company said.

© 2024 MJH Life Sciences

All rights reserved.